AMADIS Oncolung. Development of a test for the non-invasive early diagnosis of lung cancer based on molecular markers, images and Big DataoncoLung Dx tools.
AMADIS Oncolung is a collaborative R&D project with companies created to develop a test for the non-invasive early diagnosis of lung cancer based on molecular markers, images, and Big DataoncoLung Dx tools.
It is led by Dr. Rubén Pío and is funded by CPP2021-008336 MCIN/AEI/10.13039/ 501100011033 and by the European Union-NextGenerationEU/PRTR.
- Convocation: FIMA 2021 MCI - AEI PUBLIC-PRIVATE PARTNERSHIP PROJECTS
- Reference: CPP2021-008336
- Start date: June 1, 2022
- End date: May 31, 2025
- Funder: Ministerio de Ciencia e Innovación
- Nature of project: National
- Award year 2022